Chromocell Therapeutics Corporation(NYSE MKT:CHRO) 
Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the development and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. Its lead comp...
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-12-30
P
O 0.63
H 0.65
L 0.60
C 0.63
V 111,124
10EMA 0.63
20EMA 0.63
60EMA 0.63
120EMA 0.63
250EMA 0.63